CS22891A2 - Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases - Google Patents
Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseasesInfo
- Publication number
- CS22891A2 CS22891A2 CS91228A CS22891A CS22891A2 CS 22891 A2 CS22891 A2 CS 22891A2 CS 91228 A CS91228 A CS 91228A CS 22891 A CS22891 A CS 22891A CS 22891 A2 CS22891 A2 CS 22891A2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- virusinduced
- diseases
- derivatives
- treatment
- application
- Prior art date
Links
- OGBVRMYSNSKIEF-UHFFFAOYSA-N Benzylphosphonic acid Chemical class OP(O)(=O)CC1=CC=CC=C1 OGBVRMYSNSKIEF-UHFFFAOYSA-N 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3882—Arylalkanephosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4003054A DE4003054A1 (de) | 1990-02-02 | 1990-02-02 | Verwendung von benzylphosphonsaeurederivaten zur behandlung von durch viren verursachte krankheiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS22891A2 true CS22891A2 (en) | 1991-09-15 |
Family
ID=6399265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS91228A CS22891A2 (en) | 1990-02-02 | 1991-01-31 | Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5242908A (pt) |
| EP (1) | EP0440148A1 (pt) |
| JP (1) | JPH0532682A (pt) |
| KR (1) | KR910021407A (pt) |
| CN (1) | CN1053793A (pt) |
| AU (1) | AU639746B2 (pt) |
| CA (1) | CA2035494A1 (pt) |
| CS (1) | CS22891A2 (pt) |
| DE (1) | DE4003054A1 (pt) |
| HU (1) | HU208400B (pt) |
| IE (1) | IE910363A1 (pt) |
| IL (1) | IL97110A0 (pt) |
| PT (1) | PT96626A (pt) |
| TW (1) | TW207953B (pt) |
| ZA (1) | ZA91762B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300687A (en) * | 1991-07-18 | 1994-04-05 | Ortho Pharmaceutical Corporation | Trifluoromethylbenzylphosphonates useful in treating osteoporosis |
| AU4848193A (en) * | 1992-09-23 | 1994-04-26 | Upjohn Company, The | Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents |
| US5508273A (en) * | 1993-12-30 | 1996-04-16 | Ortho Pharmaceutical Corporation | Substituted phosphonic acids and derivatives useful in treating bone wasting diseases |
| CN1302001C (zh) * | 2005-01-20 | 2007-02-28 | 申厚宝 | 邻氯苄基膦酸二甲酯生产工艺 |
| US20070004937A1 (en) * | 2005-06-29 | 2007-01-04 | Ferro Corporation | Methods for the preparation of phosphonic acid derivatives |
| MX2011000051A (es) * | 2008-07-07 | 2011-07-28 | Fasgen Inc | Nuevos compuestos, composiciones farmaceuticas que contienen los mismos, metodos para usar los mismos, y metodos para preparar los mismos. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3161667A (en) * | 1960-01-04 | 1964-12-15 | Monsanto Co | Vinylidene aromatic phosphorus monomers |
| US3538196A (en) * | 1963-12-11 | 1970-11-03 | Hooker Chemical Corp | Bis(oxypropylated pentaerythritol) oxypropylated pentaerythritol phosphonate |
| US3346669A (en) * | 1964-04-06 | 1967-10-10 | Chemagro Corp | Halo-phosphorus compounds and process for their preparation |
| US3363032A (en) * | 1964-06-11 | 1968-01-09 | Monsanto Co | Long chain aliphatic benzylphosphonic acids, esters and salts |
| US3555123A (en) * | 1966-06-23 | 1971-01-12 | Milton H Fischer | Di-omega-alkynyl aryl(arylalkyl) phosphonates |
| CH506948A (de) * | 1969-04-02 | 1971-05-15 | Ciba Geigy Ag | Fungizides Mittel |
| FR2358882A2 (fr) * | 1976-07-22 | 1978-02-17 | Hoffmann La Roche | Nouveaux derives de peptides d'acides phosphonique et phosphinique |
| US4182759A (en) * | 1978-06-05 | 1980-01-08 | Sterling Drug Inc. | Arylalkyl and aryloxyalkyl phosphonates and use as antiviral agents |
| DK463679A (da) * | 1978-11-10 | 1980-06-06 | Sandoz Ag | Phosphonsyreesterderivater |
| DE3001065A1 (de) * | 1980-01-12 | 1981-07-16 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von optischen aufhellern |
| FR2512039B1 (fr) * | 1981-08-26 | 1985-10-11 | Ato Chimie | Composition de resine synthetique ayant une bonne resistance au feu renfermant un polycarbonate, un additif ignifugeant phosphore, et eventuellement d'autres additifs et/ou des charges et objets conformes |
| JPS602570A (ja) * | 1983-06-20 | 1985-01-08 | Dainippon Printing Co Ltd | 両面接着テ−プ自動貼着装置 |
| CH660305A5 (de) * | 1984-10-05 | 1987-04-15 | Schering Spa | Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren. |
| GB8501374D0 (en) * | 1985-01-18 | 1985-02-20 | Wellcome Found | Treatment of aids |
-
1990
- 1990-02-02 DE DE4003054A patent/DE4003054A1/de not_active Withdrawn
- 1990-10-12 TW TW077108577A patent/TW207953B/zh active
-
1991
- 1991-01-28 EP EP91101097A patent/EP0440148A1/de not_active Withdrawn
- 1991-01-31 CS CS91228A patent/CS22891A2/cs unknown
- 1991-01-31 IL IL97110A patent/IL97110A0/xx unknown
- 1991-01-31 PT PT96626A patent/PT96626A/pt unknown
- 1991-02-01 KR KR1019910001735A patent/KR910021407A/ko not_active Application Discontinuation
- 1991-02-01 ZA ZA91762A patent/ZA91762B/xx unknown
- 1991-02-01 AU AU70164/91A patent/AU639746B2/en not_active Ceased
- 1991-02-01 IE IE036391A patent/IE910363A1/en unknown
- 1991-02-01 JP JP3031339A patent/JPH0532682A/ja active Pending
- 1991-02-01 CA CA002035494A patent/CA2035494A1/en not_active Abandoned
- 1991-02-01 US US07/648,622 patent/US5242908A/en not_active Expired - Fee Related
- 1991-02-01 HU HU91365A patent/HU208400B/hu not_active IP Right Cessation
- 1991-02-01 CN CN91100604A patent/CN1053793A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR910021407A (ko) | 1991-12-20 |
| US5242908A (en) | 1993-09-07 |
| ZA91762B (en) | 1991-10-30 |
| JPH0532682A (ja) | 1993-02-09 |
| IL97110A0 (en) | 1992-03-29 |
| AU639746B2 (en) | 1993-08-05 |
| CA2035494A1 (en) | 1991-08-03 |
| DE4003054A1 (de) | 1991-08-08 |
| TW207953B (pt) | 1993-06-21 |
| CN1053793A (zh) | 1991-08-14 |
| IE910363A1 (en) | 1991-08-28 |
| EP0440148A1 (de) | 1991-08-07 |
| HUT56498A (en) | 1991-09-30 |
| PT96626A (pt) | 1991-10-15 |
| AU7016491A (en) | 1991-08-08 |
| HU910365D0 (en) | 1991-08-28 |
| HU208400B (en) | 1993-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9000206A0 (en) | Treatment of conditions & diseases | |
| AU8392291A (en) | Tachykinin agonists for treatment of alzheimer's disease | |
| AU6905391A (en) | Methods and compositions for the treatment of hodgkin's disease | |
| EP0331620A3 (en) | Agent for the treatment of parkinson's disease | |
| IL86423A0 (en) | Pharmaceutical compositions for the treatment of alzheimer's disease | |
| AU4759390A (en) | Method of medical treatment of alzheimer's disease | |
| IT9041503A0 (it) | Dispositivo per la cura chirurgica dell'ametropia | |
| IL98387A0 (en) | Pyridyl-benzoic acid derivatives for treating leukotriene-related diseases | |
| FR2616831B1 (fr) | Structure de type alveolaire pour l'enterrement de restes humains | |
| CS22891A2 (en) | Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases | |
| IT9086204A0 (it) | Metodo per la cura dell'impotenza erettiva maschile | |
| IL104132A0 (en) | Compositions for the treatment of mammalian diseases | |
| ZA914435B (en) | Treatment of disease | |
| EP0419998A3 (en) | Use of alkylphosphonic acid derivatives for the treatment of psoriasis | |
| ZA914369B (en) | Amide linked pyridyl-benzoic acid derivatives for treating leukotriene-related diseases | |
| AP9000180A0 (en) | Pharmaceutical composition for the treatment of protozoal diseases | |
| AU2564188A (en) | Agent for the treatment of heart disease | |
| IE871907L (en) | "methods for treatment of sundamaged human skin with¹retinoids" | |
| CS158090A2 (en) | Application of lignosulphonic or naphthalenesuphonic acid's salts for gelatine microbushing construction | |
| CS26690A2 (en) | Preparation of clofibric acid's 2-halogenethylesters | |
| HU903177D0 (en) | Medical preparation for treating keratoconical changes of the cornea | |
| IE883282L (en) | Treatment of bone diseases | |
| CS26490A2 (en) | Method of clofibric acid's 2-halogenethylesters preparation | |
| AU619410B2 (en) | Method of treatment using 17 beta-cyclopropylaminoandrostene derivatives | |
| GB9025154D0 (en) | Treatment of lung diseases |